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Patient and Professional Factors That Impact
the Perceived Likelihood and Confidence of
Healthcare Professionals to Discuss
Implantable Cardioverter Defibrillator
Deactivation in Advanced Heart Failure
Results From an International Factorial Survey
Loreena Hill, PhD; Sonja McIlfatrick, PhD; Brian J. Taylor, PhD; Tiny Jaarsma, PhD;
DebraMoser, PhD; Paul Slater, PhD; ToniMcAloon, PhD; Lana Dixon,MD; Patrick Donnelly, MD;
Anna Stromberg, PhD; Donna Fitzsimons, PhD
Background: Rate of implantable cardioverter defibrillator (ICD) implantations is increasing in patients with
advanced heart failure. Despite clear guideline recommendations, discussions addressing deactivation occur
infrequently. Aim: The aim of this article is to explore patient and professional factors that impact perceived
likelihood and confidence of healthcare professionals to discuss ICD deactivation. Methods and Results: Between
2015 and 2016, an international sample of 262 healthcare professionals (65% nursing, 24% medical) completed an
online factorial survey, encompassing a demographic questionnaire and clinical vignettes. Each vignette had 9 randomly
manipulated and embedded patient-related factors, considered as independent variables, providing 1572 unique
vignettes for analysis. These factors were determined through synthesis of a systematic literature review, a retrospective
case note review, and a qualitative exploratory study. Results showed that most healthcare professionals agreed that
deactivation discussions should be initiated by a cardiologist (95%, n = 255) or a specialist nurse (81%, n = 215). In terms
of experience, 84% of cardiologists (n = 53) but only 30% of nurses (n = 50) had previously been involved in a
deactivation decision. Healthcare professionals valued patient involvement in deactivation decisions; however, only 50%
(n = 130) actively involved family members. Five of 9 clinical factors were associated with an increased likelihood to
discuss deactivation including advanced age, severe heart failure, presence ofmalignancy, receipt ofmultiple ICD shocks,
and more than 3 hospital admissions during the previous year. Furthermore, nationality and discipline significantly
influenced likelihood and confidence in decision making. Conclusions: Guidelines recommend that healthcare
professionals discuss ICD deactivation; however, practice is suboptimal with multifactorial factors impacting on
decision making. The role and responsibility of nurses in discussing deactivation require clarity and improvement.
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There is a gap between guideline recommendationsand everyday clinical practice concerning implant-
able cardioverter defibrillator (ICD) deactivation.1 In-
creasing rates of ICD implantation and an improved
life expectancy, with many older adults living with
comorbidities, intensify the need for clarity on the role
of the ICD in the advanced stages of any illness. A re-
cent study found that 1 in 4 patients received futile and
painful shocks from the device shortly before death.2
Many factors are implicated including patients" lack
of knowledge on the device and deactivation, their life-
saving perception of the ICD,3 and the dialogue about
deactivation characterized as ‘‘too little, too late.’’1
International and interdisciplinary discrepancies
exist on who should discuss deactivation and when such
discussions should occur.4,5 In a survey of 384 Heart
Rhythm Society members,6 deactivation was considered
by most professionals questioned to be permissible if
aligned with the patient (78%, n = 296) and/or carer"s
(72%, n = 278) wishes. Studies have found nurses
reluctant to engage in discussions, assigning sole respon-
sibility for discussing and, ultimately, decision making
regarding deactivation with medical professionals.1,4
In a recent position statement from the Council on Car-
diovascular Nursing and Allied Professionals, the varied
role of healthcare professionals across Europe was high-
lighted,7 reinforcing the need to improve international
research and collaboration, as well as improve knowl-
edge on country-specific data to facilitate the develop-
ment of strategies to improve the practice of ICD
deactivation across healthcare systems. As the number
of patients with an ICD increases, there is an urgent
need to address this clinical concern to ensure quality
of life during the palliative stage of illness.
Aim
The aim of this study is to explore patient and professional
factors that impact perceived likelihood and confidence
of healthcare professionals to discuss ICD deactivation.
Methodology
Design
This cross-sectional, factorial-design study conformed
to the Declaration of Helsinki8 and was approved by
the local research ethics committee. Originally devel-
oped by Rossi and Nock9 (1982), the factorial survey
combines the strengths of random manipulation of
variables with the generalizability of a survey. The
design has been successfully used in studies, for ex-
ample, nurses" use of physical restraints,10 indicators
of acute deterioration,11 and nurses" judgment of self-
neglect.12 Through a systematic and iterative pro-
cess,13 21 factors associated with ICD deactivation
were generated from a systematic literature review,14 a
retrospective case note review,1 and qualitative explo-
ration (Supplemental Digital Content 1, http://links.
lww.com/JCN/A57). These factors were repeatedly re-
viewed and refined by 4 methodological and 3 clinical
experts for content validity, until there were 9 orthog-
onal and clinically relevant patient-related factors or
variables15Y17 for inclusion within the survey.
Study Instrument
The survey was distributed electronically using a secure
IT platform to ensure complete anonymity. Participants
received a short demographic questionnaire and a stan-
dard vignette, followed by 6 unique clinical vignettes
(Supplemetal Digital Content 2, http://links.lww.com/
JCN/A58).
Questionnaire
Demographic and experiential data were collected.
Healthcare professionals were presented with short
statements and asked to record on a 0-to-10 Likert
scale the probability of referral for ICD deactivation. A
score of 0 indicated that the patient would not be
referred, whereas a score of 10 indicated that the
healthcare professional would refer for deactivation.
Factorial Survey
The 9 patient-related factors or independent variables
were age, gender, previous discussion, heart failure
severity, comorbidities, number of admissions, number
of shocks, treatment intent, and social support. Each
factor had between 3 and 5 levels. Participants responded
to a standard vignette that allowed the researcher to
assess their engagement and comprehension of the in-
strument"s scoring system. This was followed by 6 unique
vignettes, in which the 9 evidence-based factors had been
randomly allocated. Participants" responses to vignettes
were captured by 2 dependent variables (refer to Table 1).
A total of 200 vignettes were checked by the researcher
(L.H.) before a pretest with 10 healthcare professionals
This work was supported by an HFA Nurse Fellowship training grant
and an ‘‘Opportunity-led’’ award from the Public Health Agency NI
(Research & Development Division).
The authors have no conflicts of interest to disclose.
Correspondence
Loreena Hill, PhD, School of Nursing and Midwifery, Queen’s
University, Medical Biology Centre, 97 Lisburn Road, Belfast,
Northern BT9 7BL, Ireland, UK (l.hill@qub.ac.uk).
Supplemental digital content is available for this article. Direct URL
citations appear in the printed text and are provided in the HTML and PDF
versions of this article on the journal"s Web site (www.jcnjournal.com).
This is an open-access article distributed under the terms of the
Creative Commons Attribution-Non Commercial-No Derivatives
License 4.0 (CCBY-NC-ND), where it is permissible to download and
share the work provided it is properly cited. The work cannot be
changed in any way or used commercially without permission from
the journal.
DOI: 10.1097/JCN.0000000000000500
2 Journal of Cardiovascular Nursing x Month 2018
with clinical experience of patients with an ICD. This
determined time to complete the survey and content
validity.
Sample
Access to a convenience sample of healthcare profes-
sionals involved in the daily management of patients
with an ICD was facilitated through professional orga-
nizations, for example, Irish Cardiac Society (n = 350),
British Society of Heart Failure (n = 921), and Council
on Cardiovascular Nursing and Allied Professionals
(n = 2900). The survey was promoted on websites and
news bulletins and at conference presentations. Emails
inviting participation were sent by the international
research team.
Statistical Analysis
Data were analysed using SPSS (version 22) with de-
scriptive and inferential statistics. The framework devel-
oped by Miller et al18 informed the analysis, which was
conducted at 2 levels, ‘‘patient factors or independent
variables’’ (within vignettes) followed by ‘‘professional
factors’’ (questionnaire), with significance at P e .05.
The recommended analysis for factorial surveys17 is multi-
variate regression and analysis of variance (ANOVA),
which examines the relationship between each inde-
pendent variable and each dependent variable. Multi-
variate regression, ANOVA, and independent t tests
examined each professional factor against each de-
pendent variable. Given the high level of statistical
tests conducted, multiplicity was an issue. Therefore,
a ‘‘false discovery rate’’ analysis19 was conducted, and
P values were recalibrated accordingly.
Results
A total of 457 international professionals accessed the
web link; 262 completed the survey (57% completion
rate), which included a questionnaire, a standard
vignette, and 6 unique vignettes (1834 total vignettes,
1572 unique vignettes).
Demographic Questionnaire
The sample consisted of predominately British residents
(60%, n = 161), followed by representation from
Europe (21%, n = 56) and America (17%, n = 45). Par-
ticipants were predominately female, specialist nurses,
and those with at least 6 years (70%, n = 182) of ex-
perience. Demographic details are presented in Table 2.
Attitude Toward the Deactivation Discussion
Most healthcare professionals stated that cardiologists
(97%, n = 255) or specialist nurses (82%, n = 215)
should initiate discussions concerning ICD deactiva-
tion, with some also placing responsibility on primary
care physicians (63%, n = 166). All physicians sup-
ported this view, as did most nurses (96%, n = 163).
Four British nurses, 2 American nurses, and 1 nurse
from Europe believed that the discussion could be
initiated by a specialist nurse. Healthcare professionals
agreed that deactivation should be discussedVbefore
device implantation (81%, n = 213), when the patient"s
condition deteriorates (83%, n = 218), and at the
palliative stage (78%, n = 205). Figure 1 demonstrates
that nurses (84%, n = 167) were more in favor of
discussing ICD deactivation before implantation,
compared with physicians (73%, n = 46). In contrast,
a higher percentage of physicians stated that ICD deac-
tivation should be discussed when patient"s care becomes
palliative (86%, n = 54), compared with nurses (76%,
n = 151). The presence of a deactivation policy was not
associated with the likelihood of discussing deactivation
(P = .8); however, healthcare professionals were more
confident in making this decision when a deactivation
policy was present (P = .03).
TABLE 1 Example of a Clinical Vignette and 2
Dependent Variables
You review a 59-year-old man with moderate heart failure
(NYHA III) and bowel cancer. He has had one admission
over the past year and has experienced more than one
shock. Medical records show no previous discussion
about deactivation with documented management plan
to be referral for cardiac transplant. The patient lives
with family who share healthcare decisions.
Dependent variables:
1. What is the likelihood that you would discuss ICD
deactivation with this patient?
2. How confident are you in the decision you have justmade?
Clinical factors or independent variables are in italics.
TABLE 2 Demographic and Professional
Characteristics of Participants (N = 262)
Characteristics n (%)
Gender
Female 193 (74)
Age, mean (SD), y 45.8 (8.9); range,
26Y65
Discipline
Nursing 170 (65)
Medical 63 (24)
Cardiac physiologist (technician) 29 (11)
Current role
Specialist nurse 150 (57)
Cardiologist 46 (18)
Cardiac physiologist 29 (11)
Other (ie, general nurse/physician,
physiotherapist)
24 (9)
Electrophysiologist 13 (5)
Time in current role, y
G1 11 (4)
1Y5 68 (26)
6Y10 59 (23)
910 123 (47)
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Most professionals (87%, n = 232) expressed that
they did not have ethical or legal concerns concerning
ICD deactivation. Independent t test found no signifi-
cant difference in attitude between European profes-
sionals, compared with American colleagues (P = .36).
Experience of Involvement in the
Deactivation Decision
Nearly all healthcare professionals (97%, n = 255) stated
that the patient should be included in the decision to
deactivate their device, but only 50% (n = 130) actively
involved family members. There was diversity of expe-
rience between disciplines, with 84% of physicians (n =
53) previously involved in an ICD deactivation decision,
compared with approximately one-third of nurses (30%,
n = 50) and 14% of cardiac physiologists (n = 4).
Healthcare professionals ranked their likelihood to
refer patients for deactivation based on 6 clinical state-
ments. Mean values for each statement are documented
in Table 3. Results indicate that healthcare profes-
sionals are more likely to consider deactivation when a
‘‘do not resuscitate’’ order is placed or when the patient
requests comfort care.
Factorial Survey
A total of 262 participants reported on 1 standard and
6 randomly generated vignettes, generating 1834 vignettes
for analysis. Responses to the standard vignette were con-
sistent for both outcome variablesV‘‘likelihood of
discussing deactivation’’ (mean [SD], 2.60 [2.11]) and
‘‘confidence in the decision made’’ (mean [SD], 7.96
[2.8]). The standard vignette was not included in further
analysis, rendering 1572 unique vignettes for multiple
regression and ANOVA. False discovery rate analysis
found that 1 variableV‘‘number of admission’’ (P = .04)
Vwhich when the P value was adjusted, was no longer
significant (P = .07) (refer to Table 4).
Patient Factors That Impact Perceived
Likelihood and Confidence to Discuss Implantable
Cardioverter Defibrillator Deactivation
The 9 independent variables explained 10% of the vari-
ance (adjusted R2 = 0.10) in healthcare professionals"
likelihood of discussing deactivation. Five independent
variables were significantly related to their likelihood
of discussing deactivationVpatient age, comorbidities,
number of admissions, number of shocks experienced,
and heart failure severity. Healthcare professionals were
more likely to discuss deactivation when the patient was
of an advanced age (P = .01), had a history of bowel
cancer (P G .01), had more than 3 hospital admissions
over the preceding 12 months (P G .01), had receipt of
multiple shocks (P G .01), and experienced severe (New
York Heart Association class IV) heart failure symp-
toms (P G .01).
The relationship between the 9 independent variables
and professional confidence was found to be significant
(P G .01); however, it could only explain 1% of the
variance (adjusted R2 = 0.013). Three factors had a
significant impact, with healthcare professionals more
confident in decision making when the patient had a
previous in-depth discussion on deactivation (P = .04),
experienced severe heart failure (P = .02), or lived with
and was supported by family in healthcare decisions
(P = .03). Table 4 outlines the relationship between
independent variables and dependent variables.
Professional Factors That Impact Perceived
Likelihood and Confidence to Discuss Implantable
Cardioverter Defibrillator Deactivation
Six healthcare professional characteristics, namely, coun-
try of origin, gender, discipline, time in current role, times
initiated a deactivation discussion, and ethical and legal
concerns, explained 3% of the variance (adjusted R2 =
0.026) in likelihood of discussing deactivation. Vari-
ables of country of origin, discipline, and times initiated
deactivation discussion had a significant impact (P G .01);
for example, healthcare professionals were more likely
to discuss deactivation if they were American (P G .01)
or physicians (P = .04) and had initiated a discussion
concerning deactivation on multiple occasions (P G .01).
Mean results of likelihood to discuss and professional
characteristics are graphically displayed in Figure 2.
TABLE 3 Healthcare Professionals" Likelihood to Refer for Deactivation on a Likert Scale of 0Y10 (N = 262)
Likert Scale
DNR
Actioned
Comfort
Care
Palliative
Care Referral
Requests
Deactivation
Less Than
12 mo to Live
Multiple
Shocks
Mean (SD) score 9.89 (1.86) 9.70 (2.03) 8.75 (2.39) 8.23 (2.80) 7.56 (2.88) 6.31 (3.52)
Abbreviation: DNR, do not resuscitate.
FIGURE 1. Percentage of healthcare professionals recommending
discussion at 3 time points (N = 262).
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The 6 professional characteristics explained 6% (ad-
justed R2 = 0.055) of the variance, with all 6 factors sig-
nificantly impacting (P G .01) professionals" confidence.
For example, male healthcare professionals (P G .01),
professionals who were American (P G .01), and those
who were physicians (P = .02), with more than 6 years
in the current post (P = .03), who initiated a deactiva-
tion discussion on multiple occasions (P G .01), and who
have no ethical or legal concerns (P = .01) were more
confident in their decision making (refer to Table 4). Mean
results of confidence in decision made and professional
characteristics are graphically presented in Figure 3.
Discussion
This study"s unique methodology, through the random
manipulation of patient-related factors, aimed to
confidently extrapolate their influence on clinical de-
cision making. Results illustrate a number of dispar-
ities in clinical practice,2 despite international guideline
recommendations.20Y22 Five patient-related factors and
3 healthcare professional factors influenced the likeli-
hood that ICD deactivation would be discussed. The
percentage of variance predicted by our regression
models was small; however, in comparison with similar
published factorial studies,23,24 confidence can be
placed on our findings. Physicians and, more specifi-
cally, cardiologists accepted the responsibility to
discuss and decide whether to deactivate an ICD, more
than nurses. Finally, there was a consensus of agree-
ment among healthcare professionals on the need to
more actively include patients and family members in
discussions and decisions that affect care.
TABLE 4 Independent Variables and Professional Characteristics With Dependent Variables (N = 262)
Independent and
Professional Variables Levels
Likelihood to Discuss
Deactivation, Mean (SD)
Confidence in the
Decision Made, Mean (SD)
Patient age, y 39 5.99 (3.29) Not significant
59 6.37 (3.13)
75 6.96 (3.05)
86 7.36 (2.96) (P = .01)a
Comorbidities Bowel cancer 7.38 (2.8) (P G .01)a Not significant
Renal failure 6.78 (3.04)
Dementia 5.96 (3.38)
No. admissions None Not significant Not significant
1
93
No. shocks experienced None 6.11 (3.18) No significant
91 6.60 (3.10)
Multiple shocks 6.95 (3.20) (P G .01)a
Heart failure severity NYHA II 5.69 (3.21) 8.17 (2.35)
NYHA III 6.44 (3.12) 8.28 (2.34)
NYHA IV 7.48 (2.95) (P G .01)a 8.54 (2.28) (P = .02)a
Previous discussion No previous discussion Not significant 8.26 (2.41)
Brief previous discussion 8.17 (2.30)
Previous in-depth discussion 8.57 (2.24) (P = .04)a
Social support Lives alone Not significant 8.15 (2.39)
Lives alone with support 8.36 (2.27)
Liveswith family who share decisions 8.50 (2.31) (P = .03)a
Country of origin Ireland and Europe 6.33 (3.150) 8.39 (2.19)
United Kingdom 6.41 (3.07) 8.07 (2.35)
United States 7.32 (3.50) (P G .01)a 9.19 (2.26) (P G .01)a
Discipline Medical 6.88 (3.35) (P = .04)a 8.98 (1.96) (P = .02)a
Nursing 6.63 (3.08) 8.14 (2.45)
Healthcare science 5.46 (3.20) 8.17 (2.06)
Times initiated discussion 1Y10 6.47 (3.02) 8.36 (2.21)
10Y25 6.88 (3.25) 8.69 (2.08)
Multiple 7.93 (3.31) (P G .01)a 9.90 (1.39) (P G .01)a
Time in the current role, y G1 Not significant 7.84 (2.33)
1Y5 8.08 (2.25)
6Y10 8.43 (2.35)a
910 8.47 (2.36) (P = .03)a
Gender Male Not significant 8.84 (1.98) (P G .01)a
Female 8.15 (2.43)
Ethical or legal concerns Yes Not significant 7.85 (2.64)
No 8.41 (2.28) (P = .01)a
Abbreviation: NYHA, New York Heart Association.
aAnalysis of variance post hoc with adjusted P values.
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Cross-Country Variation
The study confirmed that professional practice was
influenced by several key clinical indicators, which
support and extend published findings of a profes-
sional survey conducted by Marinskis et al25 (2010).
Their study examined professional attitudes from 47
centers of the European Heart Rhythm Association"s
research network and found that 83% would consid-
er deactivation if the patient was experiencing multiple
shocks; however, only 4% of professionals routinely
discussed deactivation. The reluctance to discuss palli-
ative issues varies internationally, as illustrated in the
study by Voohees et al.26 Only less than half of Italian
physicians (43%) would not inform competent pa-
tients of their prognosis, compared with most Swedish
physicians (89%). In addition, physicians in Belgium
(89%) were more likely (P G .01) to disclose informa-
tion to next of kin, compared with Dutch physicians
(48%). In contrast, a survey of Dutch and Swedish
nurses (n = 275) found that Dutch nurses were more
willing to discuss prognosis in comparison with Swedish
nurses (P G .01).4 Finally, a British study found that
53% of dying patients with an ICD (n = 23) had a dis-
cussion about prognosis, with a third of these discus-
sions (n = 17) broaching the subject of deactivation.1
This study found that American physicians and nurses
were more apt to discuss deactivation in comparison
with European colleagues, a result that both supports27
and conflicts28 with previous evidence. An American
study by Kelley et al27 surveyed 558 physicians and
found that, when presented with 5 clinical scenarios,
more than half (56%Y83%) would initiate a discussion
concerning deactivation. In contrast, Dunlay et al28
reported that most physicians (52%, n = 49) would
hesitate to discuss palliative issues. Reasons included
FIGURE 2. Professional characteristics and likelihood to discuss deactivation (N = 262).
FIGURE 3. Professional characteristics and confidence in decision (N = 262).
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personal discomfort (11%), fear of destroying hope
(9%), or lack of time (8%). In this study, most pro-
fessionals had no ethical or legal concerns29; however,
the minority who had (13%) were less confident in de-
cision making. There is increasing evidence that nurses30
and physicians31 can experience moral distress, with a
detrimental impact on clinical care. Moral distress is
the result of perceived aggressive or ‘‘futile’’ care, therefore
highlighting the need for additional support for pro-
fessionals when managing dying patients with an ICD.
In summary, there was cross-country variation in
healthcare professionals" decision to discuss ICD
deactivation, as evident in this study and the published
literature.26,27
Medical Dominance of the Final Decision
The discipline with the highest representation within
the sample was nursing (65%, n = 168), indicating their
predominance in clinical settings, high level of involve-
ment with patients with an ICD, and increased will-
ingness to participate in the survey.32,33 Specialist nurses
were patients" main professional support, possessing
evidence-based knowledge and skills to address palli-
ative concerns.4 This is reflected in our results whereby
most professionals (81%, n = 215) felt that specialist
nurses had the necessary attributes to initiate a discus-
sion about deactivation. The data, however, do expose
a lack of nursing contribution to the final decision con-
cerning deactivation, because only 30% of nurses (n =
50) within the sample reported previous involvement.
This could be explained by the structure of the healthcare
system34 and the traditional role of physicians to diag-
nose and make treatment decisions. In addition, it may
also be explained by the findings illustrated in Figure 1,
whereby nurses perceived that the best time to discuss
deactivation was before implant and not when the
patient required palliative careVthe reverse attitude
compared with physicians. Specialist nurses through
nurse-based clinics can, however, play a key role in the
effective management of patients with a cardiac device.35
Generalized reluctance to discuss palliative issues,
such as deactivation, is well recognized across all clinical
settings and professions. Potential solutions have been
suggested including additional training,4,26 with im-
proved knowledge and skills acquisition.27 An alter-
native strategy is clarification of roles and sharing of
the responsibility concerning deactivation, facilitated by
a multidisciplinary team approach. This approach has
been successfully implemented within the oncology
setting, because patients receiving care from a multi-
disciplinary team showed an improved survival,36
better patient experience, and quality of life.37
In summary, our study indicates that the current
practice of discussing and deactivating an ICD is pre-
dominantly a task performed by physicians with minor
input from specialist nurses. A paradigm shift toward a
team-based approach, as routinely used in oncology
and palliative medicine, is advocated.
Improved Inclusion of Patients and Carers
The healthcare professionals in this study agreed that
patients should be informed about deactivation before
implant and periodically during the disease trajectory,
as per clinical guidelines.21 Furthermore, the decision
to deactivate an ICD was deemed to require agree-
ment between the cardiologist, patient, and his/her
family. Healthcare professionals were more confident
being involved in such decisions when the patient ini-
tiates the conversation (mean [SD], 9.70 [2.03]) and/or
has the support of family (P = .014).
Many professionals value shared decision making
within clinical practice, which required the relay of
accurate and timely information to ensure that indi-
vidual patient"s preferences inform treatment choices.
Indeed, studies have shown that patients with an ICD
have diverse preferences to discuss ICD deactivation.14
The scientific statement published by the American
Heart Association38 provided a ‘‘road map’’ to guide
discussions and enable shared decision making, proven
to restore hope and control over illness experience as
perceived by patients and families.39 Despite studies
advising involvement of the family to provide pa-
tients" psychological support and, in some cases, to
act as surrogate decision-makers, there is limited evi-
dence of its application in practice. For example, a
recent retrospective case note review found that only 32%
of all palliative discussions had family involvement.1
Results of a survey carried out on Belgian and
Scandinavian nurses (n = 425) may provide an
explanationValthough nurses recognized the patient"s
family as important to their care, they were reluctant
to actively invite family members to be involved in the
care of the patient40 and 20% agreed with the state-
ment ‘‘I do not have time to take care of families.’’
Interestingly, the more experienced nurses and those
nurses from Scandinavian countries possessed a more
positive attitude. In summary, improved patient and
family involvement in patients" management plan is
warranted to facilitate shared clinical decision making
through the delivery of patient-centered information
and discussion.
Limitations of the study include the diverse repre-
sentation across countries and disciplines, as well as
the data collection instrument. A number of strategies
were used to promote recruitment, with the most
effective being a personalized email sent by members
of the research team. The innovative survey instrument
engaged participants as there was a complete data set
from all professionals who commenced the survey.
Despite scrupulous preparation and refinement, the 9
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independent variables only explained 10% of the var-
iance for likelihood to discuss deactivation and 3% of
the variance concerning professionals" confidence.
Similar effect sizes have been reported in previous pro-
fessional factorial surveys.23,24 It is to be acknowl-
edged that the 9 variables selected may not truly reflect
those, perhaps more implicit factors professionals base
their decision whether to discuss deactivation on. Never-
theless, results strengthen our opinion that healthcare
professionals make clinical decisions based on a multi-
tude of factors and that could be deemed idiosyncratic.
Implications for Practice
h A multidisciplinary approach is necessary to im-
prove the clinical management of the discussion and
decision concerning ICD deactivation.
h Innovative educational strategies should be devel-
oped to improve patients and family members" under-
standing of the functionality of the ICD.
h Additional training and support are required for
nurses to improve involvement in palliative discus-
sions that include ICD deactivation.
Conclusion
Decision making regarding ICD deactivation is com-
plex, multifactorial with lack of a coherent multi-
disciplinary approach to practice internationally. The
cross-country variation in attitudes and decision
making sparks concern and confirms that further
investigation is warranted on the sociocultural issues
and interesting interprofessional differences, which
may have a bearing on the overall European reluctance
to initiate a discussion leading to ICD deactivation com-
pared with American counterparts. Furthermore, ICD
deactivation is an important clinical issue for patients
and carers, with our findings supporting the value of
additional research and development on the regulatory
and medicolegal considerations of this clinical deci-
sion. Nurses play an important role in the care of pa-
tients with advanced heart disease and their families.
Our findings indicate that the nurses" role in support-
ing effective decision making requires improvement.
Advanced communication training and clinical men-
torship would aid knowledge and skills to ultimately
improve the care and reduce suffering of palliative
patients with an ICD.
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